• by Bruce Carlson
  • November 30 2018
  • HIV
  • IVD


The Latest Developments in HIV Diagnostic Testing

The Latest Developments in HIV Diagnostic Testing

HIV remains a deadly disease, but fortunately, in vitro diagnostic solutions abound for its detection and treatment progress-tracking. From utilizing dentists, to making tests available on more analyzer systems, we track the developments in HIV IVD in this articlee. More information can be found in our Worldwide Market for In Vitro Diagnostics Tests, 11th Edition

  • by Bruce Carlson
  • November 26 2018


Kalorama To Present IVD Market Findings at BIOMEDevice

Kalorama To Present IVD Market Findings at BIOMEDevice

Direct to Consumer Testing, The Status of Point of Care, Novel Biomarkers, Wearables, AI and Robotics, New EU Regulations - Kalorama will speak to these point and present top-level findings from our 11th Edition Worldwide IVD Market Study at the meeting in San Jose, CA, Dec. 4-6.

  • by Bruce Carlson
  • November 15 2018


13 Interesting Developments at #MEDICA2018

13 Interesting Developments at #MEDICA2018

From cutting-edge diagnostic tests to combating fear of spiders, it's been an interesting week. As the MEDICA 2018 total healthcare tradeshow comes to a close in Dusseldorf Germany, , we take note of these developments.

  • by Bruce Carlson
  • November 12 2018
  • IVD


7 Things We're Excited About at MEDICA 2018

7 Things We're Excited About at MEDICA 2018

As the well-attended and prestigious medical tradeshow begins in Dusseldorf, here's seven things we are finding interest in. Many in our core areas of in vitro/in vivo diagnostics, but there are some interesting device therapies that can't be ignored. Watch for more developments as the meeting continues.

  • by Bruce Carlson
  • November 12 2018


Big Developments in DTC Testing Space

Big Developments in DTC Testing Space

Kalorama predicted a large DTC market back in 2016. Some of that was predicated on the expected growth of startups. But we also had our eye on large players. Now both LabCorp and Quest have made different moves towards the same direction: allowing the consumer to order tests.


18 Billion-Dollar Market for Precision Cancer Diagnostics

18 Billion-Dollar Market for Precision Cancer Diagnostics

The global volume of precision cancer diagnostic procedures is forecast to reach 970 million in 2023, up 5.1% annually from 2018. Several trends and factors will contribute to growth, according to a new report from Kalorama Information.